Science Daily12h
A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Leisure-time physical activity is key for type 2 diabetes risk reduction, research shows
Researchers have found that engaging in moderate to vigorous physical activity during leisure time, regardless of ...
Every 34 Seconds, Someone Dies From Cardiovascular Disease: Key Risk Factors Continue To Rise
Driven by rising rates of high blood pressure, obesity, and other key risk factors, heart disease remains the leading cause ...
Telling people they've got prediabetes has caused needless panic
EXCLUSIVE: The latest figures are all too clear: we are in the middle of an epidemic of diabetes.
6 numbers to know about heart and brain health
Cardiovascular diseases claim more lives in the U.S. than all forms of cancer and accidental deaths combined, according to ...
Healthline4d
NSYNC’s Lance Bass Says Managing Type 1.5 Diabetes Is a 'Full-Time Job'
NSYNC’s Lance Bass shares his journey with type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA). The ...